Breast cancer, version 3.2018: Featured updates to the NCCN Guidelines Guidelines
| Authors: | Goetz, M. P.; Gradishar, W. J.; Anderson, B. O.; Abraham, J.; Aft, R.; Allison, K. H.; Blair, S. L.; Burstein, H. J.; Dang, C.; Elias, A. D.; Farrar, W. B.; Giordano, S. H.; Goldstein, L. J.; Isakoff, S. J.; Lyons, J.; Marcom, P. K.; Mayer, I. A.; Moran, M. S.; Mortimer, J.; O’Regan, R. M.; Patel, S. A.; Pierce, L. J.; Reed, E. C.; Rugo, H. S.; Sitapati, A.; Smith, K. L.; Smith, M. L.; Soliman, H.; Telli, M. L.; Ward, J. H.; Young, J. S.; Shead, D. A.; Kumar, R. |
| Title: | Breast cancer, version 3.2018: Featured updates to the NCCN Guidelines |
| Abstract: | These NCCN Guidelines Insights highlight the updated recommendations for use of multigene assays to guide decisions on adjuvant systemic chemotherapy therapy for women with hormone receptor–positive, HER2-negative early-stage invasive breast cancer. This report summarizes these updates and discusses the rationale behind them. © JNCCN—Journal of the National Comprehensive Cancer Network. |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 17 |
| Issue: | 2 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2019-02-01 |
| Start Page: | 118 |
| End Page: | 126 |
| Language: | English |
| DOI: | 10.6004/jnccn.2019.0009 |
| PUBMED: | 30787125 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Source: Scopus |
